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Abstract
Leg ulcers remain an increased burden to healthcare cost and morbidity in
modern society. While most leg ulcers are venous in origin, recognition and
prompt identification of concomitant arterial occlusive disease is critical to
determine underlying aetiology and subsequent management. This integrative
review presents the current evidence to establish the role of modified compres-
sion therapy (MCT) in treatment of mixed arterial venous leg ulcers
(MAVLU). A literature search was conducted using the electronic databases
CINAHL, MEDLINE, PUBMED, and Embase. Ten studies met the eligibility
criteria and were subsequently analysed. Our review concludes that MCT, with
compression pressures between 20 and 30 mmHg, can promote healing in
MAVLU with moderate arterial insufficiency (0.5 ≤ ABPI ≤0.8). If ABPI is
<0.5, MCT can be considered once restoration of acceptable ABPI is achieved.
Intolerance, lack of response or further deterioration of disease within
3 months should prompt further arterial imaging and intervention. MCT is
generally well tolerated with no adverse outcomes reported. A holistic yet
individualised approach is vital in order to account for all factors influencing
this patient-led decision-making process, ultimately ensuring effective treat-
ment, which improves patient's quality of life and reduces socioeconomic
burden of the disease.
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1 | INTRODUCTION
Existing estimates suggest that up to 2% of people will
have a leg ulcer in their lifetime and this prevalence rises
with increasing age.1,2 Leg ulceration tend to be chronic
and recurrent3 especially among an aging society, which
poses an increased burden on healthcare costs and
increased morbidity.1,4-6 More recent data suggest that the
estimated cost of managing leg ulcers annually is over £1
billion with more than 100 000 patients with leg ulcers at
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any given time.6 Leg ulceration is a multi-factorial condi-
tion, which requires thorough assessments to identify the
underlying aetiology, and therefore, a holistic approach is
required to address the complexities of management.7
In the UK, the majority of leg ulcers are caused by
venous disease, specifically venous hypertension.7 Venous
ulceration can coexists with peripheral arterial occlusive dis-
ease (PAOD), and this occurs more frequently than PAOD
alone.8 A combination of both venous and arterial disease
may occur in 10% to 20% of individuals,9 this is often referred
to as mixed disease' due to the underlying aetiology and is
usually defined as mixed aetiology leg ulcers (MAVLU).
National Institute for Health and Care Excellence
(NICE) and Scottish Intercollegiate Guidelines Network
(SIGN) guidelines suggest that high compression bandag-
ing remains the gold standard of treatment for venous leg
ulcers, as this reduces venous hypertension and improves
calf muscle pump activity.9,10 Two fundamental physical
laws are associated with compression therapy: 1. Pascal's
law: external static pressure exerted on a confined fluid is
distributed evenly.11 2. Laplace's Law: Pressure applied
by compression is proportional to the tension at the inter-
face with the skin and inversely proportional with limb
radius (P α Tension/Radius).11 The technique surround-
ing the use of compression therapy may be explained by
these theories as variations of compression may arise
from different characteristics of the bandage and circum-
ference of the limb.
MCT involves lowering the compression pressure by
reducing the number of layers of bandage and the degree
of bandage stretch, respectively. There are clinical studies
suggesting that “reduced”, “modified”, “supervised modi-
fied” compression therapy is efficacious in selected cases
of MAVLU.12,13 Application of compression therapy
allows external pressure around the lower leg, which
lowers the radius and hence improve the flow velocity.11
Modified compression therapy (MCT), which may adopt
variable compression pressures has been shown to; assist
venous return, reduce lower limb oedema, improve lym-
phatic drainage, improve arterial perfusion and inflow,
and reduce local inflammatory effects, which results in
ulcer healing.12-15 The World Union of Wound Healing
Societies (WUWHS) classifies the strength of compression
pressures further; mild (<20 mmHg), moderate
(20-40 mmHg), strong (40-60 mmHg), and very strong
(≥60 mmHg).16
An ongoing debate surrounds the use of compression
therapy for the management of individuals with MAVLU.
Historically, there have been concerns about exacerba-
tion of limb ischaemia and hence the need to address the
arterial component of disease prior to the venous compo-
nent. However, older patients with significant co-
morbidities may not be fit for invasive revascularisation
procedures. While patients with MAVLU and severe
PAOD (ABPI < 0.5) are primarily managed by
revascularisation, the role of revascularisation in the
Key Messages
• MAVLU may be defined as the presence of
venous leg ulcers and Ankle Brachial Pressure
Index (ABPI) of <0.8. Other alternative
methods to determine the severity of arterial
disease and guide subsequent treatment
include absolute ankle and toe pressures, with
less than 50 and 30 mmHg, respectively, indi-
cating significant compromise in perfusion
mandating subsequent revascularisation
• MAVLU with moderate Peripheral Arterial
Occlusive Disease (PAOD) (ABPI between 0.5
and 0.8) may benefit from modified compression
therapy (MCT) at a range of 20 to 30 mmHg with
good tolerance and no adverse effect reported.
Healing outcome for patients with MAVLU is
reasonable, however, generally worse than
patients with venous leg ulcer (VLU).Further
evaluation with revascularisation investigation
and procedures should be considered if there is
clinical deterioration or lack of response to treat-
ment within 3 months
• MAVLU with critical ischaemia (ABPI<0.5) may
be considered for modified compression therapy if
revascularisation procedures have been successful
in restoringABPI,with some studies advocating full
compression therapy. However, studies are unclear
of this evidence, as the decision for post
revascularisation compression therapy may be
deemed to be dependent on a combination of
patient's tolerance and clinical reluctance due to
risk to the graft. Overall successful revascularisation
may shorten healing time and provide symptomatic
improvement for patients withMALVU
• A holistic risk assessment by vascular surgeons
is essential to consider all risk factors and dis-
cuss the benefits versus risk of
revascularisation
• referral to local multi-disciplinary teams,
which may involve wound nurse specialists,
vascular and dermatology teams, nutrition and
dietary specialists should be considered to opti-
mise management, especially in complex cases
not responding to treatment in a set time
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management of moderate PAOD (ABPI 0.5-0.8) remains
unclear. Recent studies suggest that the venous compo-
nent of MAVLU remains the most important factor in
determination of healing of a leg ulcer.17,18 Treatment of
the underlying arterial component with revascularisation pro-
cedures has only proven to shorten the healing times and pro-
vide symptomatic relief rather than determining wound
closure.19,20 While compression therapy is the primary treat-
ment of venous leg ulcers, there remains no general consen-
sus suggested by the absence of clear clinical guidelines for
the role of compression therapy in MAVLU. As there has
been little written on the management of MAVLU, the clini-
cal evidence is sparse11 and this integrative review aims to
identify the clinical evidence for the use of compression ther-
apy in the management of MAVLU.
2 | METHODS
2.1 | Review process
Article selection process illustrated in Figure 1.
2.2 | Search strategy
A literature search was conducted using the electronic
databases CINAHL, MEDLINE, PUBMED, and Embase.
The search was up to date as of May 21st, 2019. The
search terms were categorised into two concepts: one
relating to mixed aetiology leg ulcers and another
relating to compression therapy. Both concepts were
subsequently combined using the “AND” function to
identify suitable papers. Variations on the search
terms in each heading were combined using the “OR”
function. (Table 1).
A manual search was conducted through the refer-
ence lists of retrieved articles. In total, one article was
found that matched all relevant search parameters.
Ghauri et al addressed the use of compression bandaging
in mixed arterio-venous leg ulcers and were, therefore,
included.21 To minimise the risk of missing relevant
papers, no limits were set for any participant characteris-
tics, such as age, gender, and medical history. The dates
of publication for inclusion were broad and included all
papers published after 1998.
Papers identified in 







Papers screened via 
abstract and title 
(n=54)
Full text assessed for 
relevance (n=17)



















FIGURE 1 Article selection process
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2.3 | Eligibility criteria
The review included original articles written in English
language, specifically evaluating patients with leg ulcers
comprising of both arterial and venous components
who received compression therapy. Type of articles
included were epidemiological studies, experimental
studies, randomised control trials, non-randomised con-
trol trials, cohort studies, case control studies, and
descriptive evidence such as audits and case series pub-
lished after 1998 up until the review start date of May
7th, 2019 and end date of May 21st, 2019. Papers were
excluded if they were review articles, or if they had
inadequate evidence on the use of compression therapy.
Trials were considered for inclusion if they were stud-
ies/trials evaluating compression therapies in the treat-
ment of leg ulcers with mixed arterial and venous
aetiology. Trials on other forms of systemic therapy
treatment for mixed aetiology leg ulcers were excluded
(i.e. intermittent pneumatic compression, topical agents
or dressings, wireless microcurrent stimulation, hyper-
baric oxygen).
2.4 | Study selection
Duplicates were removed after compilation of all stud-
ies identified through each database. Screening for the
relevance of the identified papers was performed based
on the title and abstract. Disagreements on inclusion
or exclusion were adjudicated by a second reviewer.
Papers selected for full text review were then re-
assessed based on the inclusion and exclusion criteria.
Where there was difficulty achieving an agreement for
inclusion/exclusion of a single study, a third reviewer
was included.
2.5 | Data extraction and analysis
Extraction of data was done independently by two
reviewers and documentation was done via Microsoft
Excel spreadsheet for data analysis. Data extracted and
pooled included study type and setting, number and
characteristics of participants, MCT (type, technique,
compression pressure), healing outcomes, arterial perfu-
sion with MCT (transcutaneous oxygen pressure, laser
doppler fluxmetry, and toe pressure). However, not all
articles included data on these measures.
Methodological quality was assessed using design-
specific forms developed from the Newcastle-Ottawa (NOS)
scale.22 A star rating was scored for each study to reflect the
level of evidence. Additional study limitations that may
introduce bias were identified. Table 2 summarises the NOS
score for each study, respectively. High level methodological
quality was found with Ghauri et al and Mosti et al studies
with good duration of follow-up and less than 20% of
patients lost to follow-up. Other studies with average or low
NOS scores were due to undefined follow-up period,
absence of control cohort, and the lack of baseline charac-
teristics to allow comparability between groups.
2.6 | Analysis of bias
Data analysis revealed that majority of the research were
observational studies with heterogeneous methodologies,
therefore, conventional bias analysis with funnel plots
was not appropriate. Table 2 summarises the limitations
of the studies.
3 | RESULTS
The search identified a total of 54 studies and 1 additional
paper were identified from the reference lists. After
screening, 17 articles underwent full text review. Articles
were screened for the use of compression therapy with
MAVLU. Ten articles were subsequently selected for
analysis (Figure 1).8,13,17,18,20,21,23-26
The studies were categorised into three main themes,
which included; identifying patients with MAVLU suit-
able for MCT, the compression pressure used in MCT,
and the healing outcomes (Table 3).
Most studies were performed in the UK (n = 5),
others were carried out elsewhere in the Europe (Austria,
Italy, France, Denmark, and Greece). In terms of meth-
odology design, majority were retrospective cohort study
(n = 6), and the remainder were prospective cohort stud-
ies (n = 4). The sample size ranges from 20 to 1378.
TABLE 1 Search terms used for search strategy
Terms associated with




AND Arterial* leg* ulcer*
Compression therapy*
Mix*aetiology* Compression bandage*





Note: Terms marked with “*” demonstrate a truncation search to include all
variations on that root word, including plurals.












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































LIM ET AL. 13
Table 1 shows the specific characteristics of each study
and results. The methodological quality of each study is
shown in Table 2 along with their respective limitations.
3.1 | Identifying patients with MAVLU
suitable for MCT
The key to identifying suitability of patients for MCT is
the severity of the underlying PAOD. All 10 studies dis-
cussed the ABPI as the common initial investigation to
determine the severity of arterial impairment.
The majority of studies18,20,21,24 assessing healing out-
comes included patients with an ABPI ranging between
0.5 and 0.8 to proceed with MCT. Three studies did not
provide a specific range of ABPI of patients selected for
MCT. Adam et al categorised patients with MAVLU as
ABPI less than 0.9 without further information provided
regarding how patients were selected for different treat-
ments (e.g. revascularisation, compression, hosiery).23
Neill et al failed to define the ABPI range of selected
patients undergoing compression therapy.8 Arthur et al
recruited MAVLU patients with ABPI of less than 0.8
with no lower limit mentioned, and reported that these
patients had prior duplex or angiographic evidence of
arterial disease to reduce the risk of false inclusions.17
Equally, other studies,13,25,26 which assessed the clinical
safety and tolerability of MCT also accepted patients with an
ABPI ranging between 0.5 and 0.8 to benefit from MCT. This
is in keeping with the current consensus that this group of
patients are most likely to benefit most from MCT.12,15 Top
et al, however, selected patients with a slightly wider ABPI
range of 0.3 to 0.78 for MCT, and demonstrated that there
were no statistical effects found on distal toe blood pressure
with the use of short stretch bandage.25
Mosti et al and Stansal et al utilised systolic toe pres-
sure and systolic ankle pressure in addition to ABPI in
identifying patients suitable for MCT. This was based on
the view that the systolic toe pressure is deemed to
characterise the true perfusion pressure of the distal leg
independent from the systemic blood pressure.13,26
3.2 | Compression pressures used
in MCT
Mosti et al13 assessed 25 patients with ABPI between 0.5
and 0.8 and systolic toe pressure of >30 mmHg, and
reported safe and good tolerability of multi-layered
inelastic compression bandaging with compression pres-
sures between 30 and 40 mmHg. These pressures were
validated with a pneumatic compression device





















































































































































































































































































































































































































































































































14 LIM ET AL.
arterial perfusion on laser doppler fluxmetry (LDF),
transcutaneous oxygen pressure, and toe pressure. Con-
versely, a significant increase of LDF was observed.
Similarly, Stansal et al26 demonstrated the use of
MCT with short stretch bandaging applied at compres-
sion pressures between 20 and 30 mmHg. These pres-
sures were validated with a compression pressure
monitor KIKUHIME. MCT was reported clinically safe,
well tolerated, and did not affect the toe pressure index
or transcutaneous oxygen pressure after 24 hours in
patients with ABPI between 0.5 and 0.9, ankle
pressure > 70 mmHg, and toe pressure > 50 mmHg. No
significant difference in toe pressure and TcPO2 reported
between baseline prior and compression therapy and
after compression application at 10 minutes and
24 hours, suggesting that arterial pressure did not signifi-
cantly change.
Top et al25 failed to report information regarding the
exact duration and the pressure of its short stretch com-
pression system. The digital systolic toe blood pressure
was first measured after application of the short stretch
bandage performed by a district nurse following local
guidelines, and measurements repeated after the bandage
was removed. The authors reported no statistically signif-
icant effect in relation to digital toe blood pressure with
or without compression, suggesting that compression
itself does not significantly affect the distal arterial blood
supply.
3.3 | Clinical outcomes and Healing of
leg ulcers
Most of the studies demonstrated some positive results
showing reasonable healing rates using MCT for individ-
uals with MAVLU. All of the studies established the
healing rate by measuring the time needed for full ulcer
re-epithelisation from the initiation of revascularisation
procedure or MCT or a combination of both. Further-
more the majority of studies established that any develop-
ment of adverse effects, failure of improvement, or
deterioration within 3 months were important to prompt
further investigation by arterial imaging and
revascularisation.20,21,24
Arthur et al17 assessed the healing outcomes of MCT
in three groups of patients; 20 with venous leg ulcers,
10 MAVLU patients, and 14 MAVLU patients who
received revascularisation prior to MCT. While the exact
compression pressures used in MCT were not reported,
60% of patients with MAVLU healed, which was compa-
rable to 65% of patients with venous ulcers who received
MCT. Although there was no clear information on how
some MAVLU patients were selected for additional
revascularisation procedures, the authors reported that a
greater proportion of individuals with MAVLU healed
with revascularisation therapy prior to MCT (71% / 89%,
respectively, post angioplasty / arterial reconstruction).
The authors also noted that these patients who under-
went revascularization received adequate symptomatic
relief with reduced ulcer pain. However, healing did not
occur unless the underlying venous component of disease
was addressed, suggesting that the venous component
was the most critical factor in determining healing. There
was no comparison made between the healing times, but
the average healing time was 25 weeks in MAVLU
patients treated with MCT.
Ghauri et al21 examined patients with leg ulcers in
the community and recruited 244 patients (n = 267
limbs). Of the total number of limbs, 46 were identified
as being related to MAVLU pathology. Of these, 33 limbs
with moderate PAOD (ABPI of 0.5-0.85) were treated
with MCT at a compression pressure of 30 mmHg while
13 limbs with severe PAOD (ABPI <0.5) were treated
with arterial revascularisation. Similar to many of the
studies, any clinical deterioration or lack of response
within 3 months prompted arterial imaging and interven-
tion. Overall, 64% (n = 21) of individuals with MAVLU,
deemed to have moderate arterial disease, had healed at
36 weeks, while the remaining patients who failed to
respond (36%, n = 12) required further arterial investiga-
tion and treatment. There was no statistical difference
reported in healing outcomes between MAVLU patients
and those patients that had venous leg ulcers, with 70%
healing rates at 36 weeks. These results suggest that the
healing rates in patients with moderate MAVLU were
not significantly worse than that of patients with venous
leg ulcers, although a trend for slower healing was
observed by the authors. Among MAVLU with severe
PAOD, only 23% (n = 3) healed at 36 weeks. This study
also identified that there was a trend of slower healing in
larger ulcers (more than 3 cm); 45% versus 20% at
24 weeks (no P-value provided).
Mosti et al18 included 180 patients with recalcitrant
leg ulcers, defined by the absence of any signs of healing
seen in ulcers lasting more than 6 months. The authors
identified that 109 leg ulcers were venous in origin with
the remaining patients having MAVLU (n = 71) with
underlying moderate arterial disease (ABPI of 0.5-0.8).
Reduced stretch MCT of 40 mmHg was applied for
patients with MAVLU, while full stretch standard com-
pression of >60 mmHg was applied in patients with
venous ulcers, with compression pressure confirmed
using a Picopress device (Microlabltalia). In addition,
concurrent treatment in the form of ultrasound guided
foam sclerotherapy was used. The results showed that
25 patients were lost to follow up, including 16 from the
LIM ET AL. 15
venous group and 9 from the MAVLU group. The maxi-
mum healing time reported was 48 weeks in the venous
leg ulcer patients (P = .009) and 52 weeks in MAVLU
patients (P = .009). A multiple linear regression model
demonstrated a number of factors that had a negative
influence on healing times such as deep venous incompe-
tence, ulcer surface area, arterial disease, and ulcer dura-
tion. Overall, the study highlighted that while healing
rates were expectedly lower in recalcitrant ulcers, it can
be achieved upon adequate management.
In a hospital outpatient setting, Humphreys et al24
demonstrated good healing rates with the application of
MCT. At 36 weeks, 67.6% of patients with MAVLU and
moderate PAOD (ABPI between 0.5 and 0.85) achieved
adequate healing with the application of MCT (30 mmHg
at the ankle) in comparison with 86.8% of patients with
venous leg ulcers who received standard compression
therapy. Those patients with MAVLU and severe PAOD
(ABPI < 0.5) who received arterial imaging and potential
revascularisation were reported to have a healing rate of
53%. The healing outcomes of these three groups were
reported to have a statistically significant differ-
ence (P < .001).
Georgopoulus et al20 conducted a study on all consec-
utive patients referred for open leg ulceration and exam-
ined the effect of revascularisation procedures on the
healing of mixed ulcers. The study included patients with
MAVLU and moderate PAOD (ABPI 0.5-0.75) (n = 17),
who were given MCT of pressures of 30 mmHg, although
the study was unclear how they validated these compres-
sion pressures. Among the 17 limbs, 11 limbs healed at
an average time of 24.7 weeks and the other 6 limbs,
which failed to show signs of healing initially and under-
went subsequent revascularisation, healed in an average
time of 16 weeks. The study also included patients with
MAVLU and severe PAOD (ABPI < 0.5) (n = 3), which
underwent revascularisation to improve the ABPI to
>0.75 prior to the application of full compression ther-
apy. These limbs achieved average healing time of
17.6 weeks. Of the nine limbs revascularised, four under-
went bypass procedures and five underwent stenting.
While there were no clear inclusion or exclusion criteria
reported within the chronic leg ulcers recruited (duration
>1 month), overall the authors reported significantly
lower healing times in patients treated with
revascularisation (n = 9) than patients treated with just
compression. (16.6 versus 24.7 weeks P < .001).
Neill et al's8 study included eight patients with
MAVLU (author defined arterial disease as the absence
of any signs of critical limb ischaemia) and treated them
with inelastic 2-component Actico compression ban-
dages. While the authors did not provide any measure-
ments of the exact compression pressures applied,
complete ulcer healing was reported in all patients with
an average healing time of 6 to 30 weeks (median dura-
tion 15 weeks). No adverse events or intolerability were
reported. Other factors that influenced the healing rates,
such as the size and severity of the initial leg ulcer were
discussed.
Adams et al23 studied 555 patients prospectively in a
hospital outpatient setting presenting with chronic leg
ulcers. (n = 689 limbs) Of the total number there were
100 limbs (defined as patients with ABPI less than 0.9
with evidence of venous reflux), of which 56 underwent
arterial revascularisation, 38 had superficial venous sur-
gery, 17 had compression alone, and 3 had hosiery. The
author suggested that arterial revascularisation is not
necessary to achieve ulcer healing in most patients.
Patients in this study received a wide range of manage-
ment options, including revascularisation, venous sur-
gery, compression, hosiery, or dressings either in
combination or on their own. While the authors did not
clearly elaborate on how treatments were allocated, nor
healing outcome was measured, emphasis was given on
the importance of combined clinical and duplex assess-
ment approach in diagnosing and subsequently manag-
ing individuals with chronic leg ulcers.
4 | DISCUSSION
4.1 | Main findings
MAVLU has been recognised as a complex disease for
decades; however, there remains lack of consensus on
the definitive management of this condition, which is
reflected in the lack of existing standardised clinical guid-
ance.27 This review has included relevant studies from
current literature and has summarised key points that
are crucial in supporting formulation of clinical guide-
lines and planning for implementation into clinical
practice.
4.2 | Identifying patients with MAVLU
suitable for MCT
Lower limb claudication is a common presentation of
PAOD; symptoms such as lower limb paraesthesia or
weakness may be present although majority of patients
may be asymptomatic during the early or milder stages of
disease.15 Most patients with MAVLU commonly present
with characteristics of venous ulcers with no clinical
symptoms of PAOD. Hence, this necessitates early assess-
ment and investigation of the concomitant arterial
impairment in order to address the complexities of the
16 LIM ET AL.
underlying pathophysiology.28 Failure to identify venous
leg ulcers with underlying severe PAOD and subsequent
use compression therapy may lead to skin necrosis due to
tissue hypoxia and damage.29 Thus, it is important to
account for the patient's clinical presentation.
This review suggests that ABPI is the most frequently
used tool to identify the degree of underlying PAOD. The
severity of PAOD is commonly classified as: ABPI
between 0.8 and 1.0 (mild/insignificant arterial disease),
ABPI between 0.5 and 0.8 (moderate PAOD), <0.5
(severe PAOD), <0.3 (critical ischaemia).30 The European
Society for Vascular Surgery suggests that an ABPI of
≤0.5 is an absolute contraindication to the use of any
form of compression therapy, although it may be used
with caution in patients with an ABPI of ≤ 0.9.31 Studies
suggest that MAVLU patients with moderate PAOD
(ABPI range of 0.5-0.8) may benefit from MCT.11,12,15,32,33
Our review supports that these patients are suitable for
MCT as they are at low risk of developing adverse effects
when used appropriately.
Other vital investigations to assess patient's suitability for
MCT include; venous/arterial duplex scans,17,21,24,25,29-31,33
angiograms,17,29 toe systolic pressure reading at toe,13,26 and
absolute value of the systolic ankle pressure.13 The abso-
lute value of systolic ankle pressure has been recognised
as a more practical tool than ABPI as it characterises dis-
tal perfusion pressure independent from systemic blood
pressure.13 A systolic ankle pressure of less than
50 mmHg is accepted as an indication of compromised
distal arterial perfusion.25,26 In addition, systolic ankle
pressure also served as an important parameter in
adapting compression therapy, as the external compres-
sion pressure should not exceed this perfusion pres-
sure.13,26 Absolute systolic toe pressure also proves a
similar function, where less than 30 mmHg indicates
significant compromised perfusion with a risk of ischaemia
and amputation.13,25,26 However, systolic toe pressure is
favourable as it reflects the overall obstruction of the arterial
tree in the lower limb without being influenced by arterial
wall calcification. Arterial rigidity and medial arterial wall
calcification seen commonly in diabetic and renal disease
are known to interfere and lead to reduced diagnostic accu-
racy of ankle pressure and subsequent ABPI measure-
ments.34 ABPI measurement is not sensitive in detecting
isolated branch of arterial obstruction or distal vessel
obstruction in the foot itself. Toe pressures may also be used
to observe any changes in arterial supply distally post com-
pression as it determines it to be more reliable in assessing
microcirculation and to quantify severity of arterial occlu-
sive disease.13,26 Overall, systolic toe pressure is a non-inva-
sive, time, and cost-efficient tool that is associated to
predicting cardiovascular and overall mortality as well
amputation free survival.35 Transcutaneous oxygen pressure
may be another potential adjunct test that may aid in
assessment of the local tissue perfusion and microcircula-
tion in distal arterial disease, however, further work is
needed to confirm its role.13
In addition to assessment of suitability for MCT, it is
also vital to assess if patients with MAVLU may be suit-
able for early revascularisation. While revascularisation
is generally considered when patients with MAVLU have
severe arterial disease with predominantly proximal dis-
tribution of the lesions, it is imperative to recognise the
value of revascularisation to improve PAOD symptoms if
present.17,19,20 Symptoms such as leg pain may manifest
itself upon commencing compression therapy, thus early
revascularisation may improve tolerance and compliance
with compression therapy.26 The healing outcome of
MCT with or without revascularisation, respectively, will
be further discussed in a separate subsection. It is vital
that an individualised approach is made early in the
management of MAVLU in order to account for all fac-
tors influencing the patient-led decision-making process.
4.3 | Compression pressures used
in MCT
Compression therapy remains the cornerstone of man-
agement of patients with venous aetiology15 and good
outcomes are achieved with long-term compression ther-
apy for venous leg ulcers, as evident in a Cochrane
review.36 There is, however, caution around the use of
compression therapy in the presence of PAOD due to the
risk of ischaemic complications.
This review suggests that compression therapy has a
role in selected cases of MAVLU as the venous compo-
nent of MAVLU remains the most important factor in
determination of healing of a leg ulcer.17,18 MCT provides
graded external compression to the leg, which opposes
the hydrostatic forces of venous hypertension and
encourages systemic return via fluid leakage into the
interstitial space.37 The term “reduced compression ther-
apy” and “modified compression therapy” represent tech-
niques to allow therapeutic level of compression
pressures resulting in good healing outcomes while
avoiding undesirable ischaemic complications due to
over-compression. However, in practice, the use of
reduced stretch poses a number of challenges, for exam-
ple, the sub-bandage pressures are unknown, the ban-
dage is likely to be prone to slippage, and therefore, will
not provide the necessary compression.38 Therefore,
unless the bandage is reapplied regularly the variance in
compression is unlikely to improve outcomes.
While there is no consensus or guidelines on com-
pression pressure recommended in MCT, this review has
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shown modified compression pressure of 20 to 40 mmHg
as a suitable range for managing selected patients with
MAVLU with good tolerability, no distal perfusion com-
promise, and no reported direct adverse features. Mosti
et al suggested that pressures up to 40 mmHg, Stansal
et al proposed pressures between 20 and30 mmHg.13,26
While Top et al failed to provide any information regard-
ing the suitable range of pressures, the authors proposed
that MCT may be delivered in the form short stretch
compression therapy in selected patients.25
It is important to note that the pressures applied may
fluctuate with use. For example, Stansal et al recognised
that compression pressure drops after application of its
short stretch bandage system, and hence advocates daily
review to achieve clinical efficacy.26 However, small flu-
ctuance in compression pressure during walking is thought
to provide same benefits as a pneumatic compression tech-
nique.13,39 In addition to its venous pumping function,
MCT is said to provide a massaging effect due to contrac-
tion of the lower limb muscles while walking, which leads
to an augmentation of arterial flow through the release of
vasoactive mediators. Overall this lead to an improvement
in arterio-venous pressure gradient, and likely to explain
the clinical efficacy of MCT in MAVLU.13
4.4 | Clinical outcomes and Healing of
leg ulcers with MCT
Healing of leg ulcers is a gradual process and is defined
as the time needed for full ulcer re-epithelisation from
the initiation of revascularisation procedure or conser-
vative treatment.20 The wound bed in individuals with
MAVLU often have a higher degree of slough, infection,
and exudate.12 Although MCT may not achieve ulcer
healing in very frail and elderly patients due to contrib-
uting factors such as other medical conditions and
nutritional status, it may reduce exudate production,
skin excoriations, and reduce frequency of dressing
changes.17
While evaluating the healing outcomes after the
application of MCT in MAVLU patients with moderate
PAOD, majority of studies provided some form of com-
parison between different selected cohorts of patients;
those individuals with venous leg ulcers treated with con-
ventional standard compression therapy or/and MAVLU
with severe PAOD treated with revascularisation proce-
dures prior to compression therapy. It is important to
note that none of the studies provided a direct compari-
son between patients selected from the same cohort in
order to compare the efficacy of MCT with a control
group. It is also important to be aware that there are
other factors such as the ulcer surface area, nutritional
status, pre-existing medical condition such as diabetes
that may negatively influence ulcer healing outcome,
which is not covered within this review.18,23,26
4.5 | Healing outcomes comparing pure
venous leg ulcers and MAVLU with
moderate arterial disease
The conventional thought is that patients with venous
leg ulcers have better healing outcomes than patients
with MAVLU due to its dual aetiology.15 Arthur et al
demonstrated comparable healing outcomes between
those with venous leg ulcers and MAVLU after treatment
with MCT.17 Ghauri et al also demonstrated no statistical
difference in the healing outcomes between these two
groups although the venous ulcer group received the
standard four layer graduated Profore compression ban-
daging (50% stretch) rather than MCT (25% stretch).
However, slower healing was observed in the MAVLU
group.21 Mosti et al reported longer maximum/median
duration needed for complete healing in patients with
MAVLU treated with MCT in comparison to those
patients with venous leg ulcers group treated with stan-
dard compression therapy.18 Overall this suggests that
the advantage of conventional compression (providing
pressures of >60 mmHg) over MCT (40 mmHg) appears
to be the speed of healing rather than the proportion of
leg ulcers healed. However, the patients in this study also
had ultrasound guided foam sclerotherapy, which may
explain the improved outcomes seen in those patients
with venous ulcers. Overall good healing rates were still
achieved with MCT alone without revascularisation,
suggesting the importance of the underlying venous com-
ponent of disease in this study.
4.6 | Healing times with
revascularisation prior to MCT in MAVLU
With good healing outcomes reported by MCT alone, the
risk versus benefit of revascularisation procedures prior to
MCT should be re-considered. The procedural risk of
revascularisation and patient's co-morbidities should be
taken into account by vascular clinicians. The studies in
this review only considered revascularisation for MAVLU
patients with severe underlying PAOD or MAVLU
patients with moderate PAOD whereby there was poor
healing or inadequate response with MCT. Few studies
observed poorer healing outcomes in MAVLU with severe
PAOD but attributed this to poor compliance and inconsis-
tent post-revascularisation compression therapy. Ghauri
et al reported only 23% of leg ulcers healed at 36 weeks
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and attributed this to reluctance to apply full standard
compression therapy after revascularisation. It was, how-
ever, unclear whether participants in this study underwent
post revascularisation compression therapy.21 Humphreys
et al also reported lowest healing outcomes in MAVLU
with severe arterial disease, with the best healing out-
comes seen among patients with pure venous leg ulcers.24
While this study was unclear on the application of MCT
for patients with MAVLU and severe PAOD, the author
also acknowledged similar limitation with Ghauri et al
that the poor healing outcomes could be attributed to the
reluctance for adequate venous compression after success-
ful revascularisation due to the fear of compromising or
occluding a bypass graft or native arterial supply, although
the author did not provide specific description of the type
of vascular bypass surgery undergone in its study.24
Two studies supported better healing outcome in
MAVLU patients who received revascularisation prior to
MCT.17,20 While no clear information was given on how
MAVLU patients were selected for revascularisation prior
to MCT, Arthur et al reported that a larger proportion of
MAVLU was healed and symptomatic relief was achieved
post revascularisation.17 Georgopoulus et al also reported
significantly shorter healing times when MAVLU
patients were treated with revascularisation prior to full
compression therapy in comparison with MCT alone.20
Overall, revascularisation prior to compression therapy
in MAVLU may have a role in shorter healing times. As
described in previous section, early revascularisation may
also improve clinical symptoms of peripheral arterial dis-
ease, and subsequently improve tolerance and compliance
to compression therapy. It is, therefore, critical to develop a
therapeutic strategy that includes treating the arterial com-
ponent of the disease as it has an important impact on qual-
ity of life and economic burden of the disease.20 Equally,
consistency in post-revascularisation compression therapy
affects the healing rates as poor healing outcomes are attrib-
uted to the inadequate management of the venous compo-
nent of MAVLU.17,21,24 It is important that the decision for
revascularisation performed by the vascular team should be
based on a holistic approach of the overall risk assessment.
Factors, which should be accounted includes the clinical
severity, co-morbidities, procedural risk, and anatomical fit-
ness for the specific procedure.
In this review, the majority of studies demonstrated that
MCT has promising results with good healing rates of
MAVLU, with no pressure-related skin damage or hypoxia-
related pain reported. Where there is lack of healing despite
MCT, this may be a sign of diminishing arterial supply and
this should prompt further arterial imaging and treatment.
Regular assessments with the measurement of the compres-
sion pressures are equally important to maintain optimal
compression, as the pressure may decrease with use,18 and
can also be affected by the calf circumference, which may
change. It is imperative to assess other factors, which may
also influence the healing rates, including the size and
severity of leg ulcer on initial presentation.8 Other risk fac-
tors for poorer healing outcomes include smoking, diabetes,
age, gender, hyperlipidaemia, arteriosclerosis, renal insuffi-
ciency, hyperviscosity, hypercoagulability, and associated
vasculitis.15 The challenge for clinicians is to be adequately
trained and competent to evaluate, plan, and implement
appropriate therapeutic treatment based on their detailed
knowledge of the patient's presentation and investigations.
When cases are complex, early input from the local special-
ist vascular team is imperative and involvement of other
members of the multidisciplinary team (dermatology, pain
specialist, and nutritional team should be considered.).7
The growing disease burden of leg ulcers requires criti-
cal attention, and urgent optimisation of clinical pathways
and guidelines is needed to ensure good clinical practice
and improve variation in wound care.27 Clinical awareness
of mixed aetiology leg ulcers needs to be advocated and
included in initial assessment. While this review has pro-
vided key evidence to inform clinical practice, further high-
quality clinical research is needed to ensure vital up-to-date
evidence-based results to support the clinical use of MCT in
patients with MAVLU. Support at a regional and national
level is needed to allow planning for implementation into
clinical practice. Since this review was undertaken in May
2019, the National Wound Care Strategy Programme
(NWCSP) has developed evidence-informed recommenda-
tion and outlines pathways to support development of local
protocols in preventing, assessing, and treating patients with
leg ulcers.40 The body recognises the importance of optimi-
sing the correct use of healthcare resources while improving
healing, and signpost clinicians to relevant clinical guide-
lines or evidence, with the aim of ultimately providing a
national equitable, accessible, and standardised care.
5 | CONCLUSION
MAVLU may be classified according to the severity of
arterial insufficiency, which is based on the ABPI. There
are currently no standardised guidelines available for the
management of MAVLU in the United Kingdom. This
review suggests that MCT may be used safely in patients
with moderate arterial insufficiency (0.5 ≤ ABPI ≤0.8)
while patients with critical limb ischaemia (ABPI <0.5)
should not receive compression therapy prior to
revascularisation procedures. Modified compression ther-
apy may, however, be considered if revascularisation pro-
cedures have been successful and improvement of ABPI
is achieved. Patients with MAVLU who fit the above
criteria may benefit from MCT with compression
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pressures ranging between 20 and 30 mmHg as good out-
comes with acceptable healing times have been recorded.
Clinical deterioration or lack of signs of improvement
within 3 months are indications that an assessment for
revascularisation should be considered. A holistic yet
individualised approach is vital, in order to account for
all factors influencing this patient-led decision-making
process. Improving clinical symptoms of PAOD in
patients with MAVLU with early revascularisation
should be considered in the early stages of management
to increase patient's tolerance and compliance to MCT.
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